Media Trust Score100%

Roche shells out $250M to acquire Good Therapeutics and its preclinical oncology program

Roche announced it will acquire Good Therapeutics, a Seattle-based preclinical biotech, for $250 million. The deal makes Roche responsible for …

  • You already voted!
  • Read More